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Escherichia coli 0157:H7 strain 933 contains two distinct toxin-converting phages (933J and 933W). The
biologic activities and antigenic relationship between the toxins produced by 933J and 933W lysogens of E. coli
K-12, as well as the homology of the genes that encode the two toxins, were examined in this study. The 933J
and 933W toxins, like Shiga toxin produced by Shigella dysenteriae type 1, were cytotoxic for the same cell lines,
caused paralysis and death in mice, and caused fluid accumulation in rabbit ileal segments. The cytotoxic
activity of 933J toxin for HeLa cells was neutralized by anti-Shiga toxin, whereas the activity of 933W toxin was
not neutralized by this antiserum. In contrast, an antiserum prepared against E. coli K-12(933W) neutralized
933W toxin but not 933J toxin or Shiga toxin. For E. coli 933, most of the cell-associated cytotoxin was
neutralized by anti-Shiga toxin, whereas most of the extracellular cytotoxin was neutralized by anti-933W
toxin. However, a mixture of these antisera indicated the presence of both toxins in cell lysates and culture
supernatants. Among 50 elevated cytotoxin-producing strains of E. coli, we identified 11 strains isolated from
cases of diarrhea, hemorrhagic colitis, or hemolytic uremic syndrome that produced cell-associated cytotoxins
which were neutralized by the 933W antitoxin. Southern hybridization studies showed that the cloned toxin
structural genes from phage 933J hybridized with DNA from phage 933W under conditions estimated to allow
no more than 26% base-pair mismatch. These findings indicate that E. coli produces two genetically related but
antigenically distinct cytotoxins with similar biologic activities which we propose to name Shiga-like toxins I
and II. Strains of E. coli that produce elevated levels of Shiga-like toxin I or Shiga-like toxin II, or both, have
been associated with the clinical syndromes of diarrhea, hemorrhagic colitis, and hemolytic uremic syndrome.

Escherichia coli serotype 0157:H7

was

incriminated

shaw, and B. Rowe, Letter, Lancet ii:216, 1983; H. R.
Smith, N. P. Day, S. M. Scotland, R. J. Gross, and B.
Rowe, Letter, Lancet i:1242-1243, 1984). E. coli 933 harbors
two distinct toxin-converting phages designated 933J and
933W (17). The cytotoxin produced in large amounts by E.
coli K-12 lysogenized with phage 933J can be neutralized by
antiserum against Shiga toxin (17). The structural genes for
this toxin were cloned from phage 933J DNA and shown by
Southern hybridization to have homology with DNA from S.
dysenteriae type 1 and Shigellaflexneri (13). Recent studies
in our laboratory demonstrated that the cytotoxin produced
by E. coli K-12(933W) was not neutralized by anti-Shiga
toxin, in contrast with our original report on 933W toxin (17).
The purposes of this investigation were to compare the
biologic activities and antigenic specificities of the 933J and
933W toxins and to determine whether their structural genes
are homologous.
(A preliminary report of this work was presented at the
Twenty-first Joint Conference on Cholera sponsored by the
U.S.-Japan Cooperative Medical Sciences Program, October 21-23, 1985, at the National Institutes of Health, Bethesda, Maryland.)

as

the agent responsible for two outbreaks of hemorrhagic
colitis that occurred in the United States during 1982 (23,
26). The E. coli 0157:H7 strains isolated during these
outbreaks did not produce either heat-labile or heat-stable
enterotoxin, nor were they enteroinvasive (26). However,
two isolates from patients and an isolate (strain 933) from
ground beef, which was implicated as the vehicle in these
outbreaks, produced high levels of cell-associated and cellfree cytotoxin active on both HeLa and Vero cells (A. D.
O'Brien, T. A. Lively, M. E. Chen, S. W. Rothman, and
S. B. Formal, Letter, Lancet i:702, 1983). In Canada, strains
of E. coli 0157:H7 have been isolated from patients with
hemorrhagic colitis (20; W. M. Johnson, H. Lior, and G. S.
Bezanson, Letter, Lancet i:76, 1983) and hemolytic uremic
syndrome (6; M. A. Karmali, B. T. Steele, M. Petric, and C.
Lim, Letter, Lancet i:619-620, 1983), and these strains have
been shown to produce a cytotoxin active on Vero cells.
Toxin from E. coli 933 was purified to apparent homogeneity
and shown to have biologic activities similar to those of
Shigella dysenteriae type 1 (Shiga) toxin: both toxins were
cytotoxic for selected cell lines in vitro, paralytic and lethal
for mice, and enterotoxic in ligated rabbit ileal segments (8;
A. D. O'Brien, T. A. Lively, T. W. Chang, and S. W.
Gorbach, Letter, Lancet ii:573, 1983).
Production of elevated levels of a HeLa or Vero cell
cytotoxin by E. coli is associated with temperate bacteriophages (17, 24; S. M. Scotland, H. R. Smith, G. A. Will*

MATERIALS AND METHODS
Bacterial strains. E. coli 0157:H7 strain 933 was obtained
from G. K. Morris, Centers for Disease Control, Atlanta,
Ga. E. coli C600(933J) and E. coli C600(933W) were constructed by lysogenizing E. coli K-12 strain C600 with phage
933J or phage 933W (17). E. coli H30 (026:H11) was
obtained from J. Konowalchuk, Bureau of Microbial Haz-
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ards, Ottawa, Canada. S. dysenteriae type 1 strain 60R was
obtained from S. B. Formal, Walter Reed Army Institute of
Research, Washington, D.C. Clinical isolates of E. coli were
obtained from M. A. Karmali, Hospital for Sick Children,
Toronto, Canada; from D. Sherwood, Moredun Research
Institute, Edinburgh, Scotland; from J. G. Wells, Centers
for Disease Control, Atlanta, Ga.; and from B. Rowe,
Central Public Health Laboratory, London, United Kingdom. Strains were routinely stored at -70°C in Penassay
broth (Difco Laboratories, Detroit, Mich.) supplemented
with 15% glycerol.
Toxins. Bacteria were grown for 48 h in Chelex-treated
syncase medium as previously described (16). Culture supernatants were collected and bacterial lysates were prepared
either by the French press method (16) or by sonication (14).
Polyclonal rabbit antisera. Antibody to purified Shiga toxin
was raised in rabbits according to published procedures (15).
Antibody to crude 933W toxin was raised in rabbits by a
series of 13 intramuscular inoculations of extracellular culture fluid (0.2 ml) or cell extracts (0.05 to 0.2 ml) prepared
from E. coli C600(933W) as previously described (24), mixed
1:1 with incomplete Freund adjuvant, and administered at
irregular intervals over a period of 53 days.
Cytotoxicity assays. Filter-sterilized culture supernatants
and bacterial lysates were tested for cytotoxicity (4) on
HeLa cells, Vero cells, Chinese hamster ovary cells (CHO),
and mouse Y-1 adrenal cells. HeLa cells were grown in
Eagle minimal essential medium (Flow Laboratories, Inc.,
McLean, Va.); Vero and Y-1 adrenal cells were maintained
in RPMI 1640 medium (Flow Laboratories); and CHO cells
were maintained in alpha Eagle minimum essential medium
(Flow Laboratories). Media were supplemented with 10%
(vol/vol) fetal calf serum, 0.8 mM glutamine, 500 U of
penicillin G per ml, and 500 p.g of streptomycin per ml.
Microtiter plates (96-well; Costar, Cambridge, Mass.) were
inoculated with approximately 10,000 cells per well (100 VLl)
and incubated overnight at 37°C in the presence of 5% CO2.
Serial dilutions of culture supernatants or bacterial lysates
were made in cell culture medium. Samples containing 100
VLI of each dilution were added to wells of the microtiter
plates, and incubation was continued at 37°C in 5% CO2.
Vero cells were examined daily for 4 days by light microscopy for cytotoxicity, whereas the HeLa, CHO, and Y-1
adrenal cells were examined after 24 h. In each case, the 50%
cytotoxic dose (CD50) corresponded to the amount of toxin
required to kill 50% of the cells in a well.
Neutralization of cytotoxicity. Toxin from culture supernatants or sonic lysates was serially diluted (twofold for low
toxin producers or 10-fold for moderate or high toxin producers) in cell culture medium. A sample of each toxin
dilution (100 p.l) was mixed with an equal volume of one of
the antibodies described below and incubated at 37°C for 1 h
followed by overnight incubation at 4°C. Samples (100 pJ) of
each toxin-serum mixture were added to individual wells of
microtiter plates containing HeLa cells, and the cells were
examined for cytotoxic effects after incubation overnight at
37°C in 5% CO2. The antibodies used for neutralization tests
included undiluted hybridoma culture supernatant containing monoclonal antibody (MAb) 13C4 specific for the B
subunit of Shiga-like toxin (25), MAb 32D3 specific for the B
subunit of cholera toxin (5) as a negative control, and 1:50
dilutions in cell culture medium of rabbit antiserum against
purified Shiga toxin, rabbit antiserum against crude 933W
toxin, or normal rabbit serum as a negative control. Lysates
of E. coli H30 and S. dysenteriae type 1 strain 60R were
included in the neutralization assays as toxin controls to
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demonstrate the neutralizing activities of MAb 13C4 and the
rabbit antiserum against Shiga toxin. A sample was considered to contain neutralizable cytotoxin if the dose required
to kill 50% of the HeLa cells in the presence of antitoxin
antibody was at least fourfold greater for samples diluted
twofold or tenfold greater for samples diluted tenfold than
the amount of toxin required for equivalent cytotoxicity in
the presence of control antibody. These assays for Shiga-like
toxins are similar in principle to the assays used to determine
L+ and Lr doses of diphtheria toxin (28).
Mouse lethality. The lethality of crude French press lysates from E. coli 933, E. coli C600, E. coli C600(933J), and
E. coli C600(933W) was tested according to published procedures (18). The 50% lethal dose (LD50) of each toxin was
determined in the following way. Groups of five female (6 to
8 weeks old) CD-1 mice (Charles River Breeding Laboratories, Inc., Kingston, N.Y.) were inoculated intraperitoneally
with various doses of bacterial lysates diluted in phosphatebuffered saline that contained 0.1% (wt/vol) gelatin. The
mice were observed daily over a 10-day period for hind-leg
paralysis and death. The LD50s were calculated by the
method of Reed and Muench (21).
Enterotoxicity assay. French press lysates of E. coli 933, E.
coli C600, E. coli C600(933J), and E. coli C600(933W) were
tested for enterotoxic activity in ligated rabbit ileal segments
as previously described (3). One milliliter of bacterial lysate
(undiluted) was inoculated per segment. Each sample was
tested in eight ligated segments of different rabbits. A sample
was considered to contain enterotoxin if the average of the
volume-to-length ratios of the eight inoculated segments was
-1.0 ml/cm.
Restriction endonuclease digestion and hybridization analysis of 933W phage DNA. DNA from phages 933W and 933J
was prepared as previously described (17) and digested with
BamHI, Salil, or EcoRI (International Biotechnologies, Inc.,
New Haven, Conn.) according to the recommendations of
the manufacturer. DNA fragments were separated electrophoretically on 0.7% (wt/vol) agarose gels, blotted onto
nitrocellulose paper, and probed as previously described (2,
12). Probe pJN25 contains a 3.0-kilobase insert from phage
933J that encodes the 933J cytotoxin (13). Approximately
half of the 3.0-kilobase insert from phage 933J is estimated to
code for toxin, while the other half represents phage sequences. The pJN25 probe was radiolabeled by nick translation using 32P-labeled dCTP and a commercially available
kit (Bethesda Research Laboratories, Inc., Gaithersburg,
Md.). The hybridization with the 32P-labeled pJN25 probe
was performed in 5x SSPE (0.9 M NaCl, 50 mM
NaH2PO4* 2H2O, 5 mM disodium EDTA; pH 7.4) at 50°C or
65°C overnight. Washing was done at room temperature if
the hybridization was performed at 50°C or at 50°C if the
hybridization was performed at 65°C. As a control, the
digested 933W phage DNA was also probed with 32P-labeled
pBR328 (the vector plasmid contained in pJN25) under
conditions allowing approximately 36% mismatch. The blots
were exposed to Kodak X-AR film (Eastman Kodak Co.,
Rochester, N.Y.) in the presence of intensifying screens.

RESULTS
Biologic activities of the 933J and 933W toxins. As shown in
Table 1, lysates of E. coli 933, E. coli C600, E. coli
C600(933J), and E. coli C600(933W) had the same specificity
for killing cultured cells. Lysates from all four strains killed
HeLa and Vero cells but did not affect Chinese hamster
ovary cells or Y-1 adrenal cells. Culture supernatants of E.
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TABLE 1. Comparison of the biologic activities of Shiga-like toxins in cell extracts of E. colia
Cytotoxicity for:
Vero cells
CHO cells

E. coli strain
HeLa cells

933
C600

C600(933J)
C600(933W)

+
+
+
+

(high)
(low)
(high)
(moderate)

+
+
+
+

(high)
(low)
(high)
(moderate)

Y-1 cells

-

-

-

-

-

Paralysis and death
in mice

Enterotoxicity in ligated
rabbit ileal segments

+
_
+

+

+
+

+

a
Symbols: +, presence of biologic activity; -, absence of biologic activity. The level of cytotoxicity (Marques et al., in press) is given in parentheses: high,
105 to 108 CD50ml in sonic lysates; moderate, 103 to 104 CD50/ml in sonic lysates; low, 2 x 101 to 6 x 102 CD5o/ml in sonic lysates.

coli 933, E. coli C600(933J), and E. coli C600(933W) were
also selectively cytotoxic for HeLa cells (Table 2) and Vero
cells (not shown), but the culture supernatant of E. coli C600
contained no demonstrable cytotoxic activity. This is the
same pattern of cytotoxicity that has been reported for Shiga
toxin from S. dysenteriae type 1 (9, 19).
The amounts of cytotoxin present in extracts of E. coli
933, E. coli C600, E. coli C600(933J), and E. coli C600(933W)
differed greatly (Tables 1 and 2). Typically, sonic lysates of
E. coli 933 were 10,000- to 100,000-fold more toxic than
lysates from E. coli C600. Lysates from E. coli C600(933J)
were approximately 1,000-fold more toxic than lysates from
E. coli C600(933W). In contrast, the toxicity of sonic lysates
of E. coli C600 did not exceed 100 CD5W/ml and was much
lower than the toxicity of lysates from C600(933J) or
C600(933W). The cytotoxicity of extracts prepared by the
French press method was typically greater than the
cytotoxicity of sonic lysates by about 10-fold.
French press lysates of E. coli 933, E. coli C600(933J), and
E. coli C600(933W) were capable of paralyzing and killing
mice. The lysate of E. coli C600 did not cause these effects
(Table 1), presumably because the amount of cytotoxin in E.
coli C600 lysates was below the level necessary for mouse
lethality (O'Brien, et al., Lancet ii:573, 1983). In two experiments, the number of LD5so per milligrams of protein for E.
coli C600(933J) was 160 to 170, whereas for E. coli
C600(933W) the, number of LD5so per milligrams of protein
was 8 to 14. The number of CD50s corresponding to one
LD5os was 40- to 70-fold greater for 933J toxin than for the
933W toxin.
Lysates of E. coli 933, E. coli C600(933J), and E. coli

C600(933W) also had enterotoxic activity in the rabbit ligated ileal segment assay. The E. coli C600 lysate did not
cause fluid accumulation (Table 1), but because the number
of CD50s contained in 1 ml of C600 lysate was also expected
to be below the threshold for enterotoxicity (O'Brien et al.,
Lancet ii:573, 1983). Dose-response curves were not performed in ileal segments because the number of rabbits
available was limited. The data in Tables 1 and 2 demonstrate that the 933J and 933W toxins have the same kinds of
biologic activities. The greater lethality relative to
cytotoxicity for 933W toxin was reproducible and was the
most striking difference between the biologic activities of
these two toxins.
Antigenic relationships between the 933J and 933W toxins.
Cross-neutralization studies were done to assess the antigenic relationship between the 933J and 933W toxins (Table
2). In these assays, a constant amount of antibody was
mixed with various amounts of lysate or supernatant. Under
these circumstances, cytotoxicity is detected if the amount
of homologous cytotoxin exceeds the neutralizing capacity
of the antitoxin, or heterologous (non-neutralizable) cytotoxin is present, or both. To distinguish among these alternatives, samples of lysates or supematants were also treated
with mixtures of antisera capable of neutralizing the 933J and
933W toxins. The cytotoxic activities in the lysate and
culture supernatant of E. coli C600(933J) were neutralized by
monoclonal antibody against the B subunit of Shiga-like
toxin (MAb 13C4) or by anti-Shiga toxin, but they were not
neutralized by anti-933W toxin. In contrast, the cellassociated and cell-free cytotoxins from E. coli C600(933W)
were neutralized by anti-933W toxin, but they were not

TABLE 2. HeLa cytotoxicity of culture supernatants and lysates from E. coli strains in the presence or absence of antisera against
Shiga and Shiga-like toxinsa
No. of CD50 required for cytotoxicity in the presence of:
Rabbit
E. coli strain
CD50/ml
Rabbit
Rabbit
a-SLT
a-CT MAb
NRS
MAb 13C4
oa-933W
a-933W
32D3
at-Shiga

C600(933J)
Lysate
Supernatant

10,000,000
100,000

1
1

1
1

1,000
1,000

10,000
1,000

1
1

10,000
1,000

C600(933W)
Lysate
Supernatant

10,000
10,000

1
1

1
1

1
1

1
1

100
100

100
100

10,000,000
1,000,000

1
1

1
1

100
1

100
1

1
100

10,000
10,000

933
Lysate

Supernatant

a
Rabbit sera were used at dilutions of 1:50, and the monoclonal antibodies were used as undiluted hybridoma culture supernatant. Neutralization controls
included lysates from S. dysenteriae 1 strain 60R and E. coli H30. The activity in these lysates was neutralized by anti-Shiga toxin and a-Shiga-like (a-SLT) MAb
but not by a-cholera toxin (a-CT) MAb, normal rabbit serum (NRS) or rabbit anti-933W. The lysates were prepared from suspensions of bacterial cells that had
been concentrated approximately 50-fold with respect to the original cultures from which the supernatants were obtained, and the data shown are representative
of the results of many experiments. The titer of a sonic lysate of E. coli C600 was 100 CD50/ml. Culture supernatants of E. coli C600 were not cytotoxic.
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neutralized either by MAb 13C4 or by anti-Shiga toxin. This
lack of cross-neutralization demonstrates that the phageencoded 933J and 933W toxins are antigenically distinct.
The cytotoxicity of extracts of E. coli C600 was usually
neutralized by MAb 13C4 and by rabbit anti-Shiga toxin
(data not shown), confirming previous reports (16, 25), but
the rabbit anti-933W toxin did not neutralize the E. coli C600
cytotoxin. Occasionally either no activity could be detected
with E. coli C600 lysates or they exhibited low titers of
nonspecific cytotoxicity that could not be neutralized either
with anti-Shiga toxin or with anti-933W toxin.
The lysate of E. coli 933 contained a high level of cytotoxic
activity (Table 2) which was neutralized by MAb 13C4 or
anti-Shiga toxin, but which was not neutralized by rabbit
anti-933W toxin. However, a mixture of rabbit anti-Shiga
toxin and rabbit anti-933W toxin neutralized the toxicity of
the E. coli 933 lysate to a greater extent than anti-Shiga toxin
alone, suggesting that a second toxin was present at a lower
level. In contrast, the mixture of antitoxins was no more
effective against the toxin from C600(933J), or C600(933W)
than was the single, active antitoxin in the mixture. These
control experiments demonstrated that anti-Shiga toxin and
anti-933W antitoxins did not act additively or synergistically
to enhance the neutralization of 933J or 933W cytotoxin.
Therefore, the results obtained with lysates of strain 933
demonstrated the presence of two distinct cytotoxins which
were antigenically related to the toxins encoded by phages
933J and 933W.
Culture supernatants of E. coli 933 also contained 933J and
933W toxin, but their relative titers varied from one supernatant to another. This variability has led to inconsistent
neutralization results for the extracellular cytotoxicity with
anti-Shiga toxin. Our findings with this antiserum and culture
supernatants from strain 933 have ranged from complete
neutralization (O'Brien et al., Lancet i:702, 1983) to partial
or no demonstrable neutralization. A second problem that
has also led to inconsistent neutralization results is the loss
of 933W activity in some cultures of 933 left at 4°C on agar
plates for more than 3 months.
In the experiment presented in Tab-le 2, the relative titers
of 933J and 933W toxin in the culture supernatant of strain
933 were the reverse of those seen in cell lysates. The
anti-933W toxin neutralized cytotoxic activity in culture
supernatants, but neither anti-Shiga toxin nor monoclonal
antibody to Shiga-like toxin had this effect. That the 933J
toxin was in fact present in culture supernatants was evident
from the more dramatic reduction in cytotoxic activity when
a mixture of anti-Shiga toxin and anti-933W toxin was used
rather than anti-933W toxin alone.
Neutralization of the cytotoxic activity from clinical isolates
of E. coli. Marques et al. (L. R. M. Marques, M. A. Moore,
J. G. Wells, I. K. Wachsmuth, and A. D. O'Brien, J. Infect.
Dis., in press) recently surveyed 418 E. coli strains for
production of Shiga-like toxin and identified 49 elevated
cytotoxin-producing isolates (moderate and high producers).
The cell-associated cytotoxicity of 39 of these strains was
neutralized by anti-Shiga toxin, but for 10 strains the cellassociated cytotoxicity could not be neutralized by antiShiga toxin. In the present study, the antiserum prepared for
analysis of the 933W-encoded toxin was used (on the basis of
the neutralization data in Table 2) to determine whether the
cell-associated cytotoxicity of the 10 strains not neutralized
by anti-Shiga toxin could be neutralized by anti-933W crude
toxin. The isolates that produced toxin which was not
neutralized by anti-Shiga toxin included four strains
(0157:H7) from patients with hemorrhagic colitis, two
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strains (0113:H21) from patients with hemolytic uremic
syndrome, one strain (0157:H7) from a patient with diarrhea, and three strains (04:NM, 08:H9, 0149:H8) from
calves with diarrhea. The cytotoxic activity in lysates from
all 10 isolates was neutralized by the rabbit antiserum against
crude 933W toxin. In addition, the cell-associated cytotoxic
activity of one E. coli 0157:H- strain (E32511) described by
Scotland et al. (S. M. Scotland, H. R. Smith, and B. Rowe,
Letter, Lancet i:885-886, 1985) was only neutralized by
rabbit anti-933W toxin. The cytotoxic activity in culture
supernatants of E32511 and of 27 strains reported by
Marques et al. (Marques et al., in press) as not neutralized
by anti-Shiga toxin, was found in this investigation to be
neutralized by either anti-Shiga toxin plus anti-933W toxin or
anti-933W toxin alone (the 10 strains described above).
Therefore, some clinical isolates produce cytotoxin antigenically related to the 933W toxin, and this antigenic variant of
Shiga-like toxin may play a role in the pathogenesis of
diarrhea, hemorrhagic colitis, and hemolytic uremic syndrome. The relative contributions of the 933J and 933W
types of Shiga-like toxin to the virulence of E. coli strains
that produce both toxins remains to be determined.
Homology of the 9331 and 933W toxin genes. To compare
the relatedness of the toxin genes at the DNA level, Southern hybridization experiments were performed between restriction fragments of phage 933W DNA and the pJN25 DNA
probe for the intact structural genes for Shiga-like toxin from
phage 933J. Under the more stringent hybridization conditions tested, estimated to permit no more than 26% base-pair
mismatch, pJN25 hybridized to at least one band from phage
933W DNA digested with EcoRI, SalI, or BamHI, either
singly or in pairwise combinations (Fig. 1). In control experiments, labeled DNA from the pBR328 vector did not
hybridize to the restricted 933W phage DNA under less
stringent conditions, estimated to permit up to 36% mismatch (data not shown). These results demonstrate that the
cloned DNA insert is responsible for the hybridization of the
pJN25 probe with the 933W DNA and provide evidence that
the 933J and 933W toxins have homologous nucleotide
sequences. Definitive proof for their homology, however,
will require the use of probes that are known to be completely internal to the toxin structural genes.
DISCUSSION
The major conclusion from this study is that the Shiga-like
toxin encoded by phage 933W is antigenically distinct from,
but homologous with, the Shiga-like toxin encoded by phage
933J. Data from the cross-neutralization experiments with
the polyclonal antisera and with MAb 13C4, which is specific
for an epitope on the B subunit of Shiga-like toxin (25), did
not demonstrate any shared epitopes between the 933W and
933J toxins. Nevertheless, the 933J- and 933W-encoded
toxins appear to be homologous both functionally and genetically. Their similar biologic activities, as well as their
identical target cell specificities (Table 1), suggest that both
their receptor-binding function and their mode of action,
which in the case of Shiga toxin is inhibition of protein
synthesis (22), may be similar. One difference in the biologic
activities of the 933W and 933J toxins is the ratio of LD50 to
CD50 per milligram of cell lysate protein. The genetic relatedness of the 933W and 933J toxins is suggested by the
homology between the cloned 933J toxin genes and 933W
phage DNA in the Southern hybridization studies.
Evidence supporting the existence of antigenically distinct
cytotoxins from E. coli has been reported by several investigators (7, 10, 11, 24, 27; Scotland et al., Lancet i:885-886,
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Scotland et al. (Scotland et al., Lancet i:885-886, 1985)
have suggested the names verotoxin 1 (VT1) for the toxin
encoded by genes which hybridize with S. dysenteriae type
1 and E. coli H19 (026:H11) and verotoxin 2 (VT2) for an
antigenically distinct toxin produced by E. coli E32511
(0157:H-). It is now clear that Shiga-like toxin I and VT1
are different names applied to the same serological group of
toxins (13; O'Brien et al., Lancet i:702, 1983; Scotland et al.,
Lancet i:885-886, 1985). The name verotoxin has been used
in reference to the Vero cell cytotoxin from E. coli that was
originally described in 1977 by Konowalchuk et al. (11).
Thus, the term verotoxin was coined before the recognition
that the Vero cell- and HeLa cell-active toxins produced by
E. coli and S. dysenteriae 1 are antigenically related (25;
O'Brien et al., Lancet i:702, 1983). We prefer the name
Shiga-like toxin I to VT1 for the following reasons. (i) It
acknowledges the precedence of the name Shiga toxin (1; M.
Neisser, and K. Shiga, Letter, Dtsch. Med Wochenschr.
29:61, 1903) for toxins with the biological activities summarized in Table 1. (ii) It emphasizes the antigenic and genetic
relationships of the toxin with Shiga toxin. (iii) Cytotoxicity
for Vero cells is a property of many cytotoxins that is not
unique to Shiga-like toxin. Shiga-like toxin II and VT2
appear to be the same toxin as determined by neutralization
of E. coli E32511 cytotoxic activity with rabbit anti-933W
toxin. It is not yet established whether Shiga-like toxin II is
produced by bacteria other than E. coli. The definitive
relationships between the members of the family of Shigalike toxins will ultimately be defined at the genetic level by
the nucleotide sequences of their structural genes. Such
information will also provide a definitive basis for establishing a nomenclature that accurately reflects the relationships
between Shiga toxin and the Shiga-like toxins.

Shiga-like toxin from phage 933J. Hybridization of pJN25 was
performed in an aqueous solution using 5 x SSPE overnight at 65°C.
The autoradiograph represents a 4-day exposure in the presence of
an intensifying screen. Fragments of lambda DNA cut with Hindlll
(Bethesda Research Laboratories) were used as molecular-size
markers. The multiple bands observed in some of the lanes indicate
that the restriction enzyme(s) cut one or more times within the DNA
sequences which show homology with the probe.
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1985). To avoid confusion, the nomenclature for the antigenic variants should be addressed. We propose that the
name Shiga-like toxin I be applied to the 933J toxin and
related toxins which are neutralized by antiserum against
Shiga toxin from S. dysenteriae type 1 strain 60R. The name
Shiga-like toxin II is suggested for the 933W toxin and toxins
neutralized by antibodies to 933W toxin. Specific antisera
raised against each purified prototype toxin should be used
to identify which antigenic variant is produced. We have
made antibodies against purified Shiga toxin and monoclonal
antibodies against Shiga-like toxin I from E. coli, and we are
now in the process of purifying the 933W toxin and raising
polyclonal and monoclonal antibodies against it. Once purified 933W toxin is available, we will also be able to compare
directly the specific activities of the 933J and 933W toxins in
each of the available bioassays.
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